source
- Biopharma layoffs must double in second half of 2026 to match 2025 cutsThe first half of 2026 saw biopharma companies cut slightly fewer jobs than the same period a year earlier, with layoffs affecting about 2% fewer employees overall. To reach the total workforce re…
- J&J gets FDA clearance for general surgery robot; study finds 90% of approved drugs meet post-marketing commitmentsJ&J received FDA authorization for a general‑surgery robot, a notable regulatory step for the company. The FDA is also being urged to ban direct‑to‑consumer drug advertisements, highlighting ongoi…